Tags: Drug.
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics designed for the treatment of cancer.Chemical names are: Immunoglobulin G1 anti-(CD antigen CD70) (human-mouse monoclonal h1F6 heavy chain) disulfide with human-mouse monoclonal h1F6 light chain dimer Immunoglobulin G1 anti-(human CD70 antigen (CD27 ligand Tumor necrosis↑